Image

Effectiveness of OLE Airway Clearance Therapy in ICU Patients With Pulmonary Infections

Effectiveness of OLE Airway Clearance Therapy in ICU Patients With Pulmonary Infections

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This study aims to explore the application of Electrical Impedance Tomography (EIT) in evaluating the effectiveness of OLE (Oscillatory Lung Expansion) airway clearance therapy for ICU patients with pulmonary infections. The goal is to understand the treatment response differences in patients with various causes of atelectasis (lung collapse). The study will include adult patients diagnosed with pulmonary infections and admitted to the ICU. The primary endpoint of the study is the peak cough flow (CPF), which measures the patient's ability to clear secretions from the lungs through coughing.

Eligibility

Inclusion Criteria:

  1. Clearly diagnosed with pulmonary infection in the ICU, confirmed by microbiological tests (sputum culture, blood culture, etc.) or imaging tests (chest CT, chest X-ray);
  2. Age ≥ 18 years;
  3. Respiratory support is oxygen therapy (nasal cannula or face mask oxygen therapy);
  4. Sputum volume \> 30 ml/day;
  5. The patient or their legal representative signs the informed consent form.

Exclusion Criteria:

  1. Pregnant or breastfeeding women;
  2. Presence of respiratory or circulatory failure (requiring mechanical ventilation or vasopressor support to maintain circulation);
  3. Untreated tension pneumothorax;
  4. Body Mass Index (BMI) exceeding 50 kg/m²;
  5. Rib deformities or severe thoracic deformities;
  6. Contraindications for the use of EIT (such as implanted automatic cardiac defibrillators, acute chest trauma, subcutaneous implanted pumps, etc.);
  7. Early withdrawal from the study or incomplete clinical data.

Study details
    Pneumonia

NCT07395297

Chinese PLA General Hospital

14 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.